ENDOVASCULAR TRANSCATHETER PULMONARY VALVE REPLACEMENT USING BALLOON-EXPANDABLE DEVICES: A LITERATURE REVIEW

Highlights

The development of new valve devices (SAPIEN, Myval) with a large size range has significantly expanded the possibilities of endovascular treatment of pulmonary valve dysfunction. It became possible to treat pulmonary regurgitation in patients with obstructive right ventricular outflow tract and in patients with transannular patch repair of pulmonary trunk and right ventricular outflow tract enlargement. Based on the analysis of literature data, this work examines modern valve design features, indications, methods and techniques of their implantation, as well as clinical results.

Abstract

The paper analyzes the effectiveness and safety of endovascular transcatheter pulmonary valve replacement using balloon-expandable devices. The authors conducted a review of the literature on this topic, studied the available clinical trial data and case reports, and analyzed the main technical aspects of the replacement procedure. The study results helped to assess the effectiveness of the procedure, indications and complications associated with its use. It can be concluded that endovascular transcatheter pulmonary valve replacement using balloon-expandable devices is a promising alternative treatment method for certain patients with heart defects. However, further research is needed to optimize the technique and improve the results of the procedure.

1. Shimazaki Y., Blackstone E.H., Kirklin J.W. The natural history of isolated congenital pulmonary valve incompetence: surgical implications. Thorac Cardiovasc Surg 1984; 32: 257-259 doi: 10.1055/s-2007-1023399.

2. Podzolkov V.P., Samsonov V.B., Chiaureli M.R., Kokshenev I.V., Sabirov B.N., Danilov T.Yu., Kovalev D.V., Saidov M.A. Congenital heart valve diseases: modern approaches to diagnosis and surgical treatment. Byulleten’ Nauchnogo Tsentra Serdechno-Sosudistoy Khirurgii imeni A.N. Bakuleva RAMN (The Bulletin of Bakoulev Center. Cardiovascular Diseases, Russian journal). 2017; 18 (3): 271–277. doi: 10.24022/1810-0694-2017-18-3-271-277 (In Russian)

3. Warnes C.A. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 2005; 46: 1-8. doi: 10.1016/j.jacc.2009.06.048.

4. Podzolkov V.P., Yurlov I.A., Danilov T.Yu., Gadzhiyev A.A., Hasan A., Kovalev D.V., Pursanov M.G., Dontsova V.I., Astrakhantseva T.O., Chernogriuov I.Ye. Pulmonary arterial valve replacement in the late periods after radical correction of congenital heart disease with pulmonary blood flow obstruction. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2008;4: 4-11. (In Russian)

5. Powell A.J., Lock J.E, Keane J.F., Perry S.B. Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediateterm results. Circulation 1995; 92: 3282-3288. doi: 10.1161/01.CIR.92.11.3282.

6. Oosterhof T., Meijboom F.J., Vliegen H.W., Hazekamp M.G., Zwinderman A.H., Bouma B.J., van Dijk A.P., Mulder B.J. Long-term followup of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006; 27: 1478-1484. doi: 10.1093/eurheartj/ehl033.

7. Corno A.F. Valved Conduits Right Ventricle to Pulmonary Artery for Complex Congenital Heart Defects. In: Cagini L. edited. Current Concepts in General Thoracic Surgery. InTech, 2012. doi: 10.5772/51081. Available from: URL: http:///cdn.intechopen.com/pdfs-wm/41324.pdf. (accessed 23.06.2024)

8. Alekjan B. G., Podzolkov V.P., Pursanov M.G., Jurlov I.A., Sandodze T.S., Danilov T.Ju., Kovalev D.V., Doncova V.I., Shinkareva T.V. Jendovaskuljarnaja implantacija klapana legochnoj arterii u pacienta s transpoziciej magistral'nyh sosudov posle mnogojetapnoj hirurgicheskoj korrekcii. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2010;3:58-62. (In Russian)

9. Pursanov M.G., Abramyan M.A., Kurako M.M., Pardaev D.B., Dishekov M.R., Shamrin Yu.N., Bedin A.V., Efremov S.O. Transcatheter replacement of heart valves in children: the first clinical experience. Russian Journal of Endovascular Surgery. 2020; 7 (2): 149–60. doi: 10.24183/2409-4080-2020-7-2-149-160 (In Russian)

10. Bonhoeffer P., Boudjemline Y., Saliba Z., Merckx J., Aggoun Y., Bonnet D., Acar P., Le Bidois J., Sidi D., Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403-1405

11. Martin M.H., Meadows J., McElhinney D.B., Goldstein B.H., Bergersen L., Qureshi A.M., Shahanavaz S., Aboulhosn J., Berman D., Peng L., Gillespie M., Armstrong A., Weng C., Minich L.L., Gray R.G. Safety and Feasibility of Melody Transcatheter Pulmonary Valve Replacement in the Native Right Ventricular Outflow Tract: A Multicenter Pediatric Heart Network Scholar Study. JACC Cardiovasc Interv. 2018;11(16):1642-1650. doi: 10.1016/j.jcin.2018.05.051.

12. Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O., Uebing A., Dähnert I., Röhle R., Schneider H., Witsenburg M., Benson L., Gitter R., Bökenkamp R., Mahadevan V., Berger F. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-2264. doi: 10.1093/eurheartj/ehz201.

13. Cheatham S.L., Holzer R.J., Chisolm J.L., Cheatham J.P. The Medtronic Melody transcatheter pulmonary valve implanted at 24-mm diameter – it works. Catheter Cardiovasc Interv. 2013;82(5):816–823. doi:10.1002/ccd.24821

14. Malone L., Fonseca B., Fagan T., Gralla J., Wilson N., Vargas D., DiMaria M., Truong U., Browne L.P. Preprocedural Risk Assessment Prior to PPVI with CMR and Cardiac CT. Pediatr Cardiol. 2017;38(4):746-753. doi: 10.1007/s00246-017-1574-0.

15. Romans R.A., Lu J.C., Balasubramanian S., Whiteside W., Yu S., Aldoss O.T., Armstrong A.K., Boe B.A., Balzer D.T., Christensen J.T. et al. Cardiac Magnetic Resonance to Predict Coronary Artery Compression in Transcatheter Pulmonary Valve Implantation Into Conduits. JACC Cardiovasc Interv. 2022;15(9):979-988. doi: 10.1016/j.jcin.2022.02.047.

16. Morray B.H., McElhinney D.B., Cheatham J.P., Zahn E.M., Berman D.P., Sullivan P.M., Lock J.E., Jones T.K. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience Circ Cardiovasc Interv, 2013;6(5):535-42. doi:10.1161/CIRCINTERVENTIONS.113.000202

17. Patel N.D., Levi D.S., Cheatham J.P., Qureshi S.A., Shahanavaz S., Zahn E.M. Transcatheter Pulmonary Valve Replacement: A Review of Current Valve Technologies. J Soc Cardiovasc Angiogr Interv. 2022;1(6):100452. doi: 10.1016/j.jscai.2022.100452.

18. Guyon P.W.Jr., Mohammad Nijres B., Justino H., Davtyan A., Mosher B., Courelli A., Ratnayaka K., Moore J.W., El-Said H.G. Expanded Use of the One-Step Technique for Simultaneous Landing Zone Stenting and Placement of the Melody Transcatheter Pulmonary Valve. J Invasive Cardiol. 2021;33(12):E954-E959. doi: 10.25270/jic/20.00739.

19. Boudjemline Y. A new one-step procedure for pulmonary valve implantation of the melody valve: simultaneous prestenting and valve implantation. Catheter Cardiovasc Interv. 2018;91(1):64–70. doi: 10.1002/ccd.27332.

20. Jones T.K., McElhinney D.B., Vincent J.A., Hellenbrand W.E., Cheatham J.P., Berman D.P., Zahn E.M., Khan D.M., Rhodes J.F.Jr., Weng S., Bergersen L.J. Long-term outcomes after melody transcatheter pulmonary valve replacement in the US investigational device exemption trial. Circ Cardiovasc Interv. 2022;15(1), e010852. doi: 10.1161/CIRCINTERVENTIONS.121.010852.

21. Cardoso R., Ansari M., Garcia D., Sandhu S., Brinster D., Piazza N. Prestenting for prevention of melody valve stent fractures: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016;87(3):534–539. doi:10.1002/ccd.26235

22. Georgiev S., Ewert P., Eicken A., Hager A., Hörer J., Cleuziou J., Meierhofer C., Tanase D. Munich Comparative Study: Prospective Long-Term Outcome of the Transcatheter Melody Valve Versus Surgical Pulmonary Bioprosthesis With Up to 12 Years of Follow-Up. Circ Cardiovasc Interv. 2020;13(7):e008963. doi: 10.1161/CIRCINTERVENTIONS.119.008963. PMID: 32600110.

23. Abdelghani M., Nassif M., Blom N.A., Mourik M.S.V., Straver B., Koolbergen D.R., Kluin J., Tijssen J.G., Mulder B.J.M., Bouma B.J., de Winter R.J. Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J Am Heart Assoc. 2018; 7(13):e008163. doi: 10.1161/JAHA.117.008163

24. Van Dijck I., Budts W., Cools B., Eyskens B., Boshoff D.E., Heying R., Frerich S., Vanagt W.Y., Troost E., Gewillig M. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2015;101(10):788-93. doi: 10.1136/heartjnl-2014-306761.

25. Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O., Uebing A., Dähnert I., Röhle R., Schneider H., Witsenburg M., Benson L., Gitter R., Bökenkamp R., Mahadevan V., Berger F. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-2264. doi: 10.1093/eurheartj/ehz201.

26. Sadeghi S., Wadia S., Lluri G., Tarabay J., Fernando A., Salem M., Sinha S., Levi D.S., Aboulhosn J. Risk factors for infective endocarditis following transcatheter pulmonary valve replacement in patients with congenital heart disease. Catheter Cardiovasc Interv. 2019;94(4):625-635. doi: 10.1002/ccd.28474.

27. Georgiev S., Ewert P., Tanase D., Hess J., Hager A., Cleuziou J., Meierhofer C., Eicken A. A Low Residual Pressure Gradient Yields Excellent Long-Term Outcome After Percutaneous Pulmonary Valve Implantation. JACC Cardiovasc Interv. 2019;12(16):1594-1603. doi: 10.1016/j.jcin.2019.03.037.

28. McElhinney D.B., Zhang Y., Levi D.S., Georgiev S., Biernacka E.K., Goldstein B.H., Shahanavaz S., Qureshi A.M., Cabalka A.K., Bauser-Heaton H., et al. Reintervention and Survival After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2022;79(1):18-32. doi: 10.1016/j.jacc.2021.10.031.

29. McElhinney D.B., Zhang Y., Aboulhosn J.A., Morray B.H., Biernacka E.K., Qureshi A.M., Torres A.J., Shahanavaz S., Goldstein B.H., Cabalka A.K., et al. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2021;78(6):575-589. doi: 10.1016/j.jacc.2021.05.044.

30. Davtyan A., Guyon P.W., El-Sabrout H.R., Ponder R., Ramchandar N., Weber R., Zayed W., Ratnayaka K., Nigro J.J., Moore J.W., et al. Selective Valve Removal for Melody Valve Endocarditis: Practice Variations in a Multicenter Experience. Pediatr Cardiol. 2022;43(4):894-902. doi: 10.1007/s00246-021-02801-z.

31. Garay F., Webb J., Hijazi Z.M. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv. 2006;67(5):659–662. doi:10.1002/ccd.20753.

32. Geva T., Gauvreau K., Powell A.J., Cecchin F., Rhodes J., Geva J., del Nido P. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010;122(11 Suppl):S201-8. doi: 10.1161/CIRCULATIONAHA.110.951178.

33. Sinha S., Aboulhosn J., Asnes J., Bocks M., Zahn E., Goldstein B.H., Zampi J., Hellenbrand W., Salem M., Levi D. Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(3):455-463. doi: 10.1002/ccd.27973.

34. Morgan G.J., Sadeghi S., Salem M.M., Wilson N., Kay J., Rothman A., Galindo A., Martin M.H., Gray R., Ross M., Aboulhosn J.A., Levi D.S. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(2):324-329. doi: 10.1002/ccd.27932.

35. Hussan S. Suradi, Ziyad M. Hijazi. Jendovaskuljarnaja implantacija klapana Sapien v poziciju legochnoj arterii. V knige: Rengenjendovaskuljarnaja hirurgija:nacional'noe rukovodstvo pod red. B.G.Alekjana. Moscpw: izd-vo Litterra, 2017. S. 88-97. (In Russian)

36. Shahanavaz S., Zahn E.M., Levi D.S., Aboulhousn J.A., Hascoet S., Qureshi A.M., Porras D., Morgan G.J., Bauser Heaton H., et al. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. J Am Coll Cardiol. 2020;76(24):2847-2858. doi: 10.1016/j.jacc.2020.10.041. PMID: 33303074.

37. Stapleton G.E., Gowda S.T., Bansal M., Khan A., Qureshi A.M., Justino H. Sapien S3 valve deployment in the pulmonary position using the gore DrySeal sheath to protect the tricuspid valve. Catheter Cardiovasc Interv. 2020;96(6):1287–1293. doi:10.1002/ccd.29120

38. Kenny D., Rhodes J.F., Fleming G.A., Kar S., Zahn E.M., Vincent .J., Shirali G.S., Gorelick J., Fogel M.A., Fahey J.T., Kim D.W., Babaliaros V.C., Armstrong A.K., Hijazi Z.M. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv. 2018;11(19):1920-1929. doi: 10.1016/j.jcin.2018.06.001.

39. Riahi M., Blanke P., Webb J., Carere R.G. Early leaflet thrombosis complicating transcatheter implantation of a Sapien 3 valve in a native right ventricular outflow tract. Catheter Cardiovasc Interv. 2018;92(5):925–929. doi:10.1002/ ccd.27183

40. Shibbani K., Garg R., Zahn E.M., Mclennan D. Aspirin use and transcatheter pulmonary valve replacement, the need for consistency. Pediatr Cardiol. 2021;42(7):1640–1646. doi:10.1007/s00246-021-02652-8

41. Meril Life Sciences Pvt. Ltd. Myval. Available at: https://www.merillife.com/medical-devices/vascular-intervention/heart-valves/TAVR/myval (accessed 04.06.2024)

42. Rodríguez Ogando A., Ballesteros F., Martínez J.L.Z. Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve. Catheter Cardiovasc Interv. 2022;99(1):E38-E42. doi: 10.1002/ccd.29985.

43. Sivaprakasam M.C., Arvind A., Sridhar A., Gunasekaran S. First transcatheter pulmonary valve implantation – An Indian made valve. IHJ Cardiovasc Case Rep CVCR.2020;4:13–16. doi:10.1016/j.ihjccr.2020.05.005

44. Sivaprakasam M.C., Reddy J.R.V., Gunasekaran S., Sivakumar K., Pavithran S., Rohitraj G.R., Jayranganath M., Francis E. Early multicenter experience of a new balloon expandable MyVal transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits. Ann Pediatr Cardiol. 2021;14(3):293-301. doi: 10.4103/apc.apc_242_20.

45. Houeijeh A., Sudre A., Juthier F., Godart F. Pulmonary valve replacement in a large and tortuous right ventricle outflow tract with a 32 mm Myval valve under local anaesthesia: challenges and technical considerations: a case report. Eur Heart J Case Rep. 2023;7(8):ytad322. doi: 10.1093/ehjcr/ytad322.

46. Schievano S., Coats L., Migliavacca F., Norman W., Frigiola A., Deanfield J., Bonhoeffer P., Taylor A.M. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: Implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson.2007;9(4):687–95. doi: 10.1080/10976640601187596.

47. Kim G.B., Song M.K., Bae E.J., Park E.A., Lee W., Lim H.G., Kim Y.J. Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve (Pulsta Valve) implantation using knitted nitinol wire backbone and trileaflet α-gal-free porcine pericardial valve in the native right ventricular outflow tract. Circ Cardiovasc Interv. 2018;11(6):e006494. doi: 10.1161/CIRCINTERVENTIONS.118.006494.

48. Garay F., Pan X., Zhang Y.J., Wang C., Springmuller D. Early experience with the Venus p valve for percutaneous pulmonary valve implantation in native outflow tract. Neth Heart J. 2017;25:76–81. doi: 10.1007/s12471-016-0932-5.

49. Promphan W., Prachasilchai P., Siripornpitak S., Qureshi S.A., Layangool T. Percutaneous pulmonary valve implantation with the Venus P-valve: Clinical experience and early results. Cardiol Young. 2016;26(4):698-710. doi: 10.1017/S1047951115001067.